US BANCORP \DE\ - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,878
-11.8%
5570.0%0.00%
Q2 2023$14,605
+18.0%
557
+15.8%
0.00%
Q1 2023$12,381
+151.9%
481
+154.5%
0.00%
Q4 2022$4,916
-94.3%
189
-93.8%
0.00%
Q3 2022$87,000
+8.8%
3,070
-5.4%
0.00%
Q2 2022$80,000
-47.4%
3,246
+20.7%
0.00%
Q1 2022$152,000
-7.9%
2,690
+1.1%
0.00%
Q4 2021$165,000
+81.3%
2,661
+86.9%
0.00%
Q3 2021$91,000
+405.6%
1,424
+553.2%
0.00%
Q2 2021$18,000
+800.0%
218
+603.2%
0.00%
Q1 2021$2,000310.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$480,558,00031.49%
Consonance Capital Management LP 1,199,339$98,838,00011.90%
Boxer Capital, LLC 2,075,905$171,075,0006.04%
Perceptive Advisors 9,699,824$799,362,0005.19%
Orbimed Advisors 6,044,266$498,108,0005.04%
Samsara BioCapital, LLC 169,852$13,998,0001.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,375,775$113,378,0001.50%
SPHERA FUNDS MANAGEMENT LTD. 195,117$16,080,0001.09%
Artal Group S.A. 500,000$41,205,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$46,032,0000.82%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders